"Strong Demand" For Lilly's Weight-Loss Drug Overshadowed By Guidance Cut, Shares Fall

Eli Lilly & Co. shares fell in premarket trading in New York after the company slashed its full-year profit outlook, citing increased research and development expenses, despite posting first-quarter…